MYLOTARG vs XOSPATA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. MYLOTARG and XOSPATA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MYLOTARG	XOSPATA
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	GEMTUZUMAB OZOGAMICIN	GILTERITINIB FUMARATE
Manufacturer	Wyeth Pharms Inc	Astellas
Dosage forms	Injectable	Tablet
Drug class	Cd33-Directed Immunoconjugate	—
Boxed warning	Boxed warning	Boxed warning
Treats	Acute Myeloid Leukemia, Acute Myelomonocytic Leukemia	Acute Myeloid Leukemia

mylotarg xospata

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

GEMTUZUMAB OZOGAMICIN

GILTERITINIB FUMARATE

Manufacturer

Wyeth Pharms Inc

Astellas

Dosage forms

Injectable

Tablet

Drug class

Cd33-Directed Immunoconjugate

—

Boxed warning

Treats

Acute Myeloid Leukemia, Acute Myelomonocytic Leukemia

Acute Myeloid Leukemia

Frequently asked questions

What is the difference between Mylotarg and Xospata?

Mylotarg contains Gemtuzumab Ozogamicin, while Xospata contains Gilteritinib Fumarate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.